Alex Rampotas, Haematologist at UCL Cancer Institute, shared a post by Blood Cancer UK on X, adding:
“This generation of clinicians/researchers may be the first one to see good treatments and effective cures for most cancers Cost and pressures to healthcare systems would be the biggest challenge.
As we are getting better at preventing death from cardiac and other causes, it is almost a certainty that all of us we will eventually get cancer.”
Quoting Blood Cancer UK‘s post:
“They’ve been researching cancer for decades, and there’s no change. We get comments like this a lot – but the reality is research 𝘪𝘴 making a difference. Latest figures from our friends Cancer Research UK show UK cancer death rates have fallen 29% since 1989 and 11% in the last decade.
For blood cancers, there’s been real progress:
- Leukaemia death rates down 9% in 10 years.
- Hodgkin lymphoma are down 14%.
- Myeloma are down 5%.
- Non-Hodgkin lymphoma are down 9%.
This means more families getting time together, and more plans for the future made. This progress is the result of decades of research, including targeted treatments and new therapies. But more than 40,000 people are diagnosed with blood cancer every year, and some survival rates are still just 3 in 10. Research must keep going until everyone beats blood cancer.”
Other articles about Blood Cancer on OncoDaily.